The ADAMTS4 gene helps make an enzyme that breaks down parts of cartilage, the smooth tissue that cushions your joints. This gene plays an important role in normal tissue remodeling as your body repairs and renews joint surfaces. When ADAMTS4 activity is out of balance, cartilage may wear down more than it should, which can contribute to osteoarthritis and some changes in the discs of the spine. Most variants in this gene are not known to cause a single inherited condition on their own.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or to guide processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do the work. Others mainly help regulate when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medicines. For a deeper look at this topic, you can find more in the LearnHub.
Overview
ADAMTS4Gene function
What if the gene works
The ADAMTS4 gene gives instructions for a protein that helps break down a cushioning substance in cartilage. This supports normal tissue remodeling in joints and other connective tissues.
Risk
What if the gene does not work
Changes in the ADAMTS4 gene can range from milder to more severe variants. When the ADAMTS4 gene works less well, aggrecan breakdown in the extracellular matrix, the supportive material around cells, may slow and cartilage remodeling can change.
Treatment
What does that mean for your treatment
No ADAMTS4-specific treatment or management approach is currently established for people with a pathogenic or loss-of-function variant in the ADAMTS4 gene. The ADAMTS4 gene is being studied as a possible drug target in osteoarthritis and other conditions involving cartilage breakdown, but this has not led to guideline-based treatment choices.
Gene function
What if the gene works
In joints and other connective tissues, the ADAMTS4 gene helps manage the material around cells. Its protein works outside cells, where it trims large support molecules so tissues can renew and adapt to everyday use. Understanding how the ADAMTS4 gene helps maintain cartilage makes joint biology easier to picture.
The ADAMTS4 gene helps cut aggrecan, a large molecule that helps cartilage hold water and cushion pressure. This controlled trimming is part of normal cartilage renewal.
Its protein remodels the extracellular matrix (the support material between cells). This helps connective tissues adjust to routine movement, pressure, and everyday wear.
ADAMTS4 also trims other large matrix molecules in some tissues. This supports the normal structure and ongoing turnover of the tissue scaffold around cells.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, such as variations in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Studies of how ADAMTS4 gene variants affect protein function show that some DNA changes slightly alter the protein’s shape or stability, while others more clearly reduce its enzyme activity or how well it binds nearby matrix proteins. Certain variants may also limit how much protein is processed or released outside the cell. More disruptive variants can shorten the protein or change key working regions, leading to a larger drop in activity.
How variants are linked to conditions
ADAMTS4 does not yet have a broadly confirmed link to a specific health condition, although research on ADAMTS4 gene variants linked to health conditions is still evolving. Anyone with a confirmed ADAMTS4-related diagnosis should rely on guidance from their doctor or genetic counselor to understand what a particular variant may mean for them.
A variant is not necessarily a diagnosis
DNA variants are a routine part of human biology and are common throughout the general population. Most do not have a direct impact on health and simply represent normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the ADAMTS4 gene. If ADAMTS4 appears on a genetic test and you are concerned about what it means for you or your family, a doctor or genetic counselor can help put it in context.
Inheritance of ADAMTS4 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for health conditions tied specifically to the ADAMTS4 gene, so answers about how ADAMTS4 gene variants are inherited remain limited to emerging research. The ADAMTS4 gene is located on chromosome 1, which is an autosome, so each person inherits one copy from each parent. In general, changes in genes on autosomes can be passed to children of any sex.
What does my ADAMTS4 result mean for my family?
There is not yet a broadly confirmed inherited pattern tied to a specific health condition for ADAMTS4. If you have a specific ADAMTS4 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your family history and the exact finding.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the ADAMTS4 gene usually uses a blood or saliva sample. In ADAMTS4 genetic testing, a lab reads the gene's DNA code and compares it with the usual sequence to look for variants. Results may show no variant, a known variant, or a variant with uncertain meaning.
When should I consider getting a genetic test?
There is not yet a broadly established, ADAMTS4-specific clinical reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, symptoms, and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic test result can provide useful insight, but the amount it can tell you varies with the condition and the kind of variant found. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered together with other parts of care. In other situations, a genetic finding may give a clear answer. For topics like medication response, genetic results can also help put a person’s experience in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug more slowly or more quickly than another, which can change how well the treatment works or how sensitive they are to side effects. This is a common reason the same medication does not affect everyone in exactly the same way.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect responses to medications. It looks at links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes help shape how strongly a drug works or how the body processes it. This information can support more informed and more individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the ADAMTS4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about symptoms, side effects, or how well a treatment is working are best discussed with your doctor.
History
ADAMTS4 entered the scientific literature in the late 1990s, when researchers studying cartilage loss in osteoarthritis identified an enzyme that could break down aggrecan, a key part of joint cushioning. It was first widely referred to as aggrecanase-1 before being formally classified as the ADAMTS4 gene within the growing ADAMTS gene family. From these first observations, research expanded steadily. Early work helped connect cartilage biology, arthritis research, and gene discovery in a new way, especially as scientists sorted out which related enzymes were most involved in joint tissue changes. Although ADAMTS4 has not become a public facing gene, it remains an established part of the research history of osteoarthritis and cartilage degeneration.